⌘K

Login Start Free

Home/Filings/4/0001628280-25-003855

4//SEC Filing

KLEMA CATHY 4

Accession 0001628280-25-003855

CIK 0001448431other

View on SEC.gov Company Profile

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 6:50 PM ET

Size

7.1 KB

Accession

0001628280-25-003855

Insider Transaction Report

Form 4

Period: 2025-02-02

OptimizeRx CorpOPRX

Director

Transactions

Exercise/Conversion
Common Stock
2025-02-02+5,109→ 11,752 total
Exercise/Conversion
Restricted Stock Units
2025-02-02−5,109→ 0 total
From: 2025-02-02Exp: 2025-02-02→ Common Stock (5,109 underlying)

Footnotes (2)

[F1]Restricted stock units convert into common stock on a one-for-one basis.
[F2]The restricted stock units vested in full on February 2, 2025, the first anniversary of the date of grant.

Documents

1 file

4
wk-form4_1738713024.xmlPrimary
FORM 4

Issuer

OptimizeRx Corp

CIK 0001448431

Entity typeother

Related Parties

1

filerCIK 0001181157

Filing Metadata

Form type: 4
Filed: Feb 3, 7:00 PM ET
Accepted: Feb 4, 6:50 PM ET
Size: 7.1 KB

View on SEC.gov